Background: Gonadotropins represent an important component of IVF costs. In order to reduce costs, much attention was given to the type of gonadotropins (recombinant versus urinary) and the daily dose. In this study, we decided to focus on gonadotropin wastage, a neglected aspect that may harbor a relevant source of useless economic expenditure.
Materials And Methods: Women who performed oocytes collection following ovarian hyperstimulation with gonadotropins in two Italian IVF Centers were prospectively recruited. They were interviewed using a standardized questionnaire aimed at capturing drug wastage. Physicians of the participating units were blinded to the study. Recruited women were requested to hide their participation to their physicians.
Results: Three-hundred nine women were recruited. Two hundred eighty-eight (93 %; 95 %CI: 90-96 %) reported to have wasted some drug. For the whole cohort, the median [Interquartile range] IUs of drug used and drug wasted was 2,100 [1,575 - 2,850] and 825 [400 - 1,200], respectively. This corresponds to a median increase in the costs of ovarian hyperstimulation of 39 %. When data on wastage was analyzed separately for the different available drugs, a statistically significant difference emerged (p = 0.026). Reasons behind this difference could not be clearly disentangled.
Conclusions: IVF is associated with a considerable wastage of gonadotropins. Improving this aspect can allow to reduce the costs of the procedure.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ejogrb.2021.10.013 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France.
Eur J Obstet Gynecol Reprod Biol X
June 2024
Gedeon Richter Suisse, Chemin des Mines 2, 1202 Geneva, Switzerland.
Article Synopsis
- - The study compares the cost-effectiveness of the follitropin alfa biosimilar (Bemfola®) and its originator (Gonal-f®) in the French healthcare system, focusing on the cost per cumulative live-birth (CLB) based on real-world evidence rather than clinical trials.
- - A decision-tree cost-effectiveness model was used to analyze costs and cumulative live-birth rates after ovarian stimulation, including expenses from both fresh and frozen embryo transfers.
- - Results indicated that the biosimilar is more cost-effective, with a cost per CLB of €18,147 compared to €18,834 for the originator, leading to potential savings of €687 to €1,155 per
Effect of Strategic Supplementation of Dietary By-Pass Linseed Oil on Fertility and Milk Quality in Sarda Ewes.
Animals (Basel)
January 2023
Veterinary Medicine Department, Sassari University, 07100 Sassari, Italy.
The aim of the present study was to assess whether the strategic supplementation of bypass LO can enhance reproductive indexes—fertility, lambing rate, and prolificacy—in dairy Sarda ewes at the end of lactation. To assess whether LO supplementation leads to the adsorptions of PUFAs and their subsequent utilization by the body tissues, milk composition and fatty acid content were analyzed. Forty-eight ewes were assigned to the following groups: the control group (CT; N = 24), fed with a control diet without LO; and the treatment group (LO; N = 24), fed with a diet supplemented with LO (10.
View Article and Find Full Text PDFWastage of gonadotropins during IVF cycles: Real life data from two Italian infertility centers.
Eur J Obstet Gynecol Reprod Biol
December 2021
S.A.V.E. Studi Analisi Valutazioni Economiche S.r.l, Health Economics & Outcomes Research, Milan, Italy; Dept of Drug Sciences, Università degli Studi di Pavia, Pavia, Italy.
Background: Gonadotropins represent an important component of IVF costs. In order to reduce costs, much attention was given to the type of gonadotropins (recombinant versus urinary) and the daily dose. In this study, we decided to focus on gonadotropin wastage, a neglected aspect that may harbor a relevant source of useless economic expenditure.
View Article and Find Full Text PDFNegative impact of high doses of follicle-stimulating hormone during superovulation on the ovulatory follicle function in small ovarian reserve dairy heifers†.
Biol Reprod
March 2021
Molecular Reproductive Endocrinology Laboratory, Department of Animal Science, Michigan State University, East Lansing, MI 48824, USA.
When women with small ovarian reserves are subjected to assisted reproductive technologies, high doses of gonadotropins are linked to high oocyte and embryo wastage and low live birth rates. We hypothesized that excessive follicle-stimulating hormone (FSH) doses during superovulation are detrimental to ovulatory follicle function in individuals with a small ovarian reserve. To test this hypothesis, heifers with small ovarian reserves were injected twice daily for 4 days, beginning on Day 1 of the estrous cycle with 35, 70, 140, or 210 IU doses of Folltropin-V (FSH).
View Article and Find Full Text PDFMaternal heterozygous NLRP7 variant results in recurrent reproductive failure and imprinting disturbances in the offspring.
Eur J Hum Genet
August 2017
Institute of Human Genetics, University of Bonn, Bonn, Germany.
It has been shown previously that homozygous and compound-heterozygous variants affecting protein function in the human NLRP genes impact reproduction and/or fetal imprinting patterns. These variants represent so-called 'maternal effect mutations', that is, although female variant carriers are healthy, they are at risk of reproductive failure, and their offspring may develop aberrant methylation and imprinting disorders. In contrast, the relevance to reproductive failure of maternal heterozygous NLRP7 variants remains unclear.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!